Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications

• Główni autorzy: Sam M. Salek (Autor), Sarah Lussier Hoskyn (Autor), Jeffrey Johns (Autor), Nicola Allen (Autor), Chander Sehgal (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2019-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

This analysis follows our recent study showing that Canadian public reimbursement delays have lengthened from regulatory approval to listing decisions by public drug plans and delayed public access to innovative medicines, mainly due to processes following the Common Drug Review (CDR) and the pan-Ca...